K Hirashima
Overview
Explore the profile of K Hirashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirashima K, Baba Y, Watanabe M, Karashima R, Sato N, Imamura Y, et al.
Br J Cancer
. 2012 Feb;
106(5):876-82.
PMID: 22333597
Background: The mammalian target of rapamycin (mTOR) protein is important for cellular growth and homeostasis. The presence and prognostic significance of inappropriate mTOR activation have been reported for several cancers....
2.
Kashiwagi T, Matsushita T, Ito Y, Hirashima K, Sanda N, Fujimori Y, et al.
Haemophilia
. 2008 Apr;
14(3):556-63.
PMID: 18397285
Type 2A von Willebrand disease (VWD) is characterized by decreased platelet-dependent function of von Willebrand factor (VWF); this in turn is associated with an absence of high-molecular-weight multimers. Sequence analysis...
3.
Baba Y, Iyama K, Hirashima K, Nagai Y, Yoshida N, Hayashi N, et al.
Br J Cancer
. 2008 Feb;
98(5):974-80.
PMID: 18283320
Laminin-332 is major component of epithelial basement membrane, and has an important role in cell migration and tumour invasion. Recently, the phosphatidylinositol 3-kinase (PI3K) activation induced by laminin-332 during carcinogenesis...
4.
Wakao D, Murohashi I, Tominaga K, Yoshida K, Kishimoto K, Yagasaki F, et al.
Ann Hematol
. 2002 Mar;
81(3):140-6.
PMID: 11904739
Before and after therapy, serum thymidine kinase (TK) and soluble interleukin-2 receptor (sIL-2R) were serially determined in 28 patients with malignant lymphoma (ML). In 15 patients achieving and maintaining complete...
5.
Yoshida K, Suzuki T, Sakata T, Kawai N, Matsuda A, Kayano H, et al.
Intern Med
. 2001 Oct;
40(9):976-7.
PMID: 11579970
No abstract available.
6.
Yoshida K, Kusumoto S, Sugahara Y, Yagasaki F, Sakata T, Kawai N, et al.
Rinsho Ketsueki
. 2001 Oct;
42(8):644-9.
PMID: 11579505
A 41-year-old man visited his doctor in May 2000 because of a sore throat and high fever. His symptoms did not improve, despite administration of antibiotics and nonsteroidal anti-inflammatory drugs....
7.
Hirashima K, Watanabe Y
J Virol
. 2001 Aug;
75(18):8831-6.
PMID: 11507227
Tobacco mosaic virus (TMV) encodes a 30-kDa movement protein (MP) which enables viral movement from cell to cell. It is, however, unclear whether the 126- and 183-kDa replicase proteins are...
8.
Takagi T, Sawamura M, Sezaki T, Kashimura M, Tsuchiya J, Hotta T, et al.
Support Care Cancer
. 2001 Aug;
9(5):397-9.
PMID: 11497396
The object of this study was to determine the efficacy and safety of glycosylated recombinant human granulocyte colony-stimulating factor (rHuG-CSF; lenograstim) after combination chemotherapy consisting of ranimustine, vindesine, melphalan and...
9.
Granulocyte-colony stimulating factor induced intranuclear endonuclease in murine leukemia cell line
Handa A, Kashimura T, Yamamoto A, Murohashi I, Bessho M, Hirashima K
Leuk Res
. 2000 Nov;
24(12):1033-9.
PMID: 11077117
We have reported that murine leukemia cell line (C2M-A5) induced apoptosis by G-CSF. To clarify the mechanism, mRNA expression of apoptosis-related genes was studied. It revealed transient over-expression of c-myc,...
10.
Matsuda A, Jinnai I, Yagasaki F, Ito Y, Ito K, Kusumoto S, et al.
Eur J Haematol
. 2000 Sep;
65(3):210-1.
PMID: 11007059
No abstract available.